A new study published in Research describes a deep-learning system designed to assist lumbar spine MRI at the point of image ...

GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial for manganese-based MRI contrast agent under FDA Fast Track designation ...

EAT index measured by CMR may identify high-risk HFpEF patients and predict outcomes. Learn more about its role in risk ...

GE HealthCare doses first patient in phase 2/3 LUMINA trial for manganese-based MRI contrast agent, mangaciclanol: Chalfont St Giles,?UK Saturday, April 25, 2026, 12:00 Hrs [IST] ...

Avatar Medical, an award-winning company advancing medical imaging from visualization to clinical understanding, today announced FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips A few weeks ago, a research paper out of MIT (the college) crossed my desk ...

Q3 2026 Earnings Call April 29, 2026 7:30 PM EDTCompany ParticipantsGregory Brown - CEO, MD & DirectorUra Phillip ...

Scientists mapped human brain development in Down syndrome at a cellular level, discovering that stem cells "rush" to become ...

Yasmine Chinnery has always been the one to lift up those around her. Now she’s learning to receive that same support.

Scientists at UCLA have created one of the first cellular-resolution molecular maps detailing how Down syndrome alters human brain development before birth—a resource that resolves longstanding ...

This important cross-species study tests whether the corpus callosum contains parallel, segregated pathways for ipsilateral and contralateral visual-field information, rather than mixed inputs from ...

UCLA researchers created a single-cell map of the developing human neocortex in Down syndrome during a critical window of ...